Revenue | ₹686.82Cr |
Net Profits | ₹150.26Cr |
Net Profit Margins | 21.88% |
Alivus Life Sciences Ltd’s revenue jumped 5.29% since last year same period to ₹686.82Cr in the Q3 2025-2026. On a quarterly growth basis, Alivus Life Sciences Ltd has generated 13.96% jump in its revenue since last 3-months.
Alivus Life Sciences Ltd’s net profit jumped 9.71% since last year same period to ₹150.26Cr in the Q3 2025-2026. On a quarterly growth basis, Alivus Life Sciences Ltd has generated 15.56% jump in its net profits since last 3-months.
Alivus Life Sciences Ltd’s net profit margin jumped 4.2% since last year same period to 21.88% in the Q3 2025-2026. On a quarterly growth basis, Alivus Life Sciences Ltd has generated 1.4% jumped in its net profit margins since last 3-months.
The revenue for Alivus Life Sciences Ltd in the Q3 results 2025 was ₹686.82Cr.
The net profit for Alivus Life Sciences Ltd in the Q3 results 2025 was ₹150.26Cr.
The net profit margin for Alivus Life Sciences Ltd in the Q3 results 2025 was 21.88%.
The revenue for Alivus Life Sciences Ltd in the Q3 results 2024 was ₹652.30Cr.
The net profit for Alivus Life Sciences Ltd in the Q3 results 2024 was ₹136.96Cr.
The net profit margin for Alivus Life Sciences Ltd in the Q3 results 2024 was 21.00%.